Search

A recent study conducted at Kyushu University Hospital in Fukuoka, Japan, focused on new treatment strategies for patients with advanced non-small cell lung cancer (NSCLC) who have low PD-L1 expression. The study highlighted the potential benefits of combining Datopotamab deruxtecan (Dato-DXd) with pembrolizumab and platinum-based chemotherapy in this patient population. The research aims to evaluate the efficacy of this combination therapy in improving progression-free survival and overall survival outcomes for patients with non-squamous NSCLC. Financial support for the study was provided by Daiichi Sankyo Company Limited, AstraZeneca, and Merck & Company. [Extracted from the article]

A study conducted at Kurume University Hospital in Fukuoka, Japan, explored the role of CXCR4 expression and cancer-associated fibroblasts in the invasion of low-grade endometrioid carcinoma. The research found that CXCR4 expression significantly reflected myometrial invasion in endometrioid carcinoma cases, indicating its potential as an independent factor in diagnostic evaluation before treatment. This study sheds light on the heterogeneous behavior of well-differentiated endometrioid carcinoma and highlights the importance of accurate evaluation for treatment strategies, especially in cases considering fertility preservation. [Extracted from the article]

A study conducted at Kyushu University in Fukuoka, Japan, focused on the clinical significance of the tumor immune microenvironment in endometrial endometrioid carcinoma, grade 1, with DNA mismatch repair protein loss. The research highlighted the impact of the tumor immune microenvironment on clinicopathological features within the group with mismatch repair protein loss, which is the main target for immune checkpoint inhibitors in endometrioid carcinoma, grade 1. The study emphasized the need for further research, including on patients who have been administered immune checkpoint inhibitors. [Extracted from the article]

Researchers at Kyushu University conducted a study on osteonecrosis of the femoral head, focusing on the effects of the location of both anterior and lateral boundaries of the necrotic lesion on collapse progression. The study found that the location of these boundaries is crucial in predicting collapse progression, especially in hips with specific types of necrotic lesions. The research was supported by Grants-in-Aid for Scientific Research and has been peer-reviewed. For more information, the study was published in the Journal of Orthopaedic Science. [Extracted from the article]

A study conducted at Saiseikai Fukuoka General Hospital in Japan focused on the prognostic impact of the lymphocyte-to-C-reactive protein ratio (LCR) in patients who underwent surgical resection for pancreatic cancer. The research found that a low preoperative LCR was associated with poorer recurrence-free survival and overall survival rates in patients with pancreatic cancer. The study suggests that patients with low LCR may benefit from more intensive therapy, highlighting the potential of preoperative LCR as a novel prognostic marker for pancreatic cancer patients. [Extracted from the article]

A study conducted at the National Hospital Organization Kyushu Medical Center in Fukuoka, Japan, explored predictors for the clinical efficacy of tramadol in managing cancer pain. The research found that elderly patients with good performance status and liver function were more likely to benefit from tramadol therapy. The study, which involved 183 patients, concluded that tramadol could be an effective and cost-saving option for cancer pain management. The findings were published in the American Journal of Hospice and Palliative Medicine. [Extracted from the article]

A recent study from Kyushu University in Fukuoka, Japan, focused on primary intraosseous carcinoma NOS (PIOC), a rare type of odontogenic tumor with a poor prognosis. The research highlighted the transition from odontogenic keratocyst to carcinoma in PIOC, emphasizing the malignant attributes of the tumor. The study suggested that the activation of YAP signaling by Wnt/(3-catenin signaling may play a role in the pathogenesis of PIOC. [Extracted from the article]

A study conducted by researchers from Kyushu University in Fukuoka, Japan, aimed to validate a Japanese version of the Algoplus (R) tool for assessing postoperative pain in older Japanese patients with cancer. The study found that the Japanese version of Algoplus (R) is a reliable and valid instrument for nurses to assess acute postoperative pain in older Japanese patients with cancer. The scale demonstrated good internal consistency and inter-rater reliability, and it showed good responsiveness for detecting changes in pain status. The research was supported by the Japan Society for the Promotion of Science and has been peer-reviewed. [Extracted from the article]

A study conducted by researchers at Kyushu University in Fukuoka, Japan, aimed to assess the relationship between histopathological features of gastric cancer and the extracellular volume fraction (ECV) measured by preoperative equilibrium contrast-enhanced computed tomography (CECT). The study included 66 patients with surgically resected gastric adenocarcinoma who underwent preoperative multiphasic CECT. The results showed that tumor ECV determined by equilibrium CECT is significantly correlated with the pathological infiltration pattern of gastric cancer. This research provides new insights into the diagnosis and understanding of gastric cancer. [Extracted from the article]

The article offers information on the treatment of hepatocellular adenomas (HCAs) in a patient with Cornelia de Lange Syndrome (CdLS) and congenital portosystemic shunt (CPSS) using transcatheter arterial embolization (TAE). Topics discussed include the association between CdLS and HCAs; the effectiveness of TAE in reducing tumor size; and the implications for managing liver tumors in patients with CdLS.

The article focuses on the development of protein-based Fc-binding antibody-recruiting molecules (Fc-ARMs) that can induce antibody-dependent cellular cytotoxicity (ADCC) and their potential to overcome limitations of previous Fc-ARMs. Topics include the design and testing of protein-based Fc-ARMs with HER2-specific affibodies, the affinity of the Fc-ARMs for IgGs, and the requirement for further enhancement of the affinity of the antibody-binding terminus.

A recent study conducted by researchers at Daiichi University of Pharmacy in Fukuoka, Japan, highlights the potential health risks faced by family caregivers of pediatric cancer patients who are exposed to anticancer drugs. The study monitored the levels of cyclophosphamide (CPM), a commonly used anticancer drug, in the urine of caregivers and on the personal protective equipment (PPE) worn by caregivers. The results showed that CPM was detected in the urine samples of 26% of caregivers, with the highest levels observed 24 to 48 hours after drug administration. The study suggests that strict adherence to PPE protocols within 48 hours after high-dose CPM therapy can help minimize the exposure risk for caregivers. [Extracted from the article]

Researchers at Fukuoka University in Japan conducted a study on the side-to-side variability in the femoral neck anteversion angle (FA) in the Japanese population with osteonecrosis of the femoral head (ONFH). They used three-dimensional computed tomography (CT) to measure the FA and other parameters related to the acetabulum. The study found that the mean side-to-side variability in the FA was 6.7 degrees, with about 20% of patients having a variability of more than 10 degrees. There was a weak negative correlation between the FA and anterior acetabular sector angle, and a very weak positive correlation between the FA and acetabular anteversion angle. This research provides valuable insights into the variability of the FA in Japanese patients with ONFH. [Extracted from the article]

A study conducted at Kyushu University Hospital in Fukuoka, Japan, investigated the risk factors and preventive strategies for hypomagnesemia, a common side effect of cetuximab treatment in patients with head and neck cancer. The study found that prophylactic magnesium administration before cetuximab treatment was effective in preventing the need for additional magnesium repletion. The only risk factor that could be avoided with prophylactic magnesium administration was a low magnesium level before treatment. The researchers recommend this preventive intervention for managing cetuximab-induced hypomagnesemia. [Extracted from the article]

A recent study conducted by investigators from Kyushu University in Fukuoka, Japan, explores the relationship between tumor growth and neuropathic pain. The researchers focused on tactile allodynia, a condition characterized by hypersensitivity to harmless stimuli, which is often resistant to traditional pain medications. The study found that the chemokine CCL2 plays a role in cancer-induced allodynia, and inhibiting its expression in cancer cells may be an effective strategy for reducing tactile allodynia. The research suggests that the development of a controlled-release system for CCL2 expression inhibitors could be a potential treatment option for cancer-evoked neuropathic pain. [Extracted from the article]

A recent report from Kurume University in Fukuoka, Japan discusses a case of a 35-year-old Japanese woman with a rare autoimmune bullous disease called Immunoglobulin A (IgA) pemphigus. The woman also had IgA type multiple myeloma, a type of cancer. The patient experienced pruritic papulovesicles on her lower legs and trunk, and further examination revealed hyper-IgA globulinemia and increased plasma cells in the bone marrow, confirming the diagnosis of IgA type multiple myeloma. Treatment with DLd therapy was effective for both the cancer and the skin lesions. The report emphasizes the importance of clinicians being aware of the development of multiple myeloma in patients with IgA pemphigus. [Extracted from the article]

A recent study conducted by researchers at Kaohsiung Medical University in Fukuoka, Japan explored the survival benefit of metastasectomy in patients with RAS wild-type metastatic colorectal cancer (mCRC) who underwent first-line cetuximab-based chemotherapy. The study found that patients who underwent metastasectomy during or after cetuximab therapy had improved overall survival (OS) and progression-free survival (PFS) compared to those who did not. Left-sided mCRC had higher disease control rates and better OS compared to right-sided mCRC, but right-sided mCRC patients who benefited from cetuximab therapy and underwent metastasectomy had outcomes similar to left-sided mCRC patients. The optimal treatment cycle for better OS and PFS was found to be 14 cycles. The study suggests that patients who receive at least 14 cycles of treatment have a higher likelihood of metastasectomy and favorable survival outcomes. [Extracted from the article]

Researchers from Aso Iizuka Hospital in Fukuoka, Japan, have published a case report in the field of Clinical Oncology. The report describes a 46-year-old patient who developed obstructive shock and cardiac arrest due to external compression of the left pulmonary veins by a recurrent sarcoma in the mediastinum. The patient's condition improved after stenting was performed to relieve the compression, and they were discharged from the hospital. This is the first reported case of obstructive shock caused by critical pulmonary vein stenosis that responded to pulmonary vein stenting. The research has been peer-reviewed and published in the journal Internal Medicine. [Extracted from the article]

Researchers from the University of Kitakyushu in Fukuoka, Japan have developed cyclodextrin-based nanoparticles that successfully encapsulate a hydrophobic xanthone compound called alpha-mangostin (MGS). These nanoparticles showed anticancer efficacy in vivo, specifically the beta-cyclodextrin-based nanoparticles containing MGS. The researchers aimed to create libraries of beta-cyclodextrin-based nanoparticles, characterize them, and understand the relationship between physical parameters, release behavior, and anticancer efficacy. They found that the release behavior of MGS from the nanoparticles, characterized by the lifetime of complexes tau(2), can be a critical quality attribute for designing the nanoparticles. [Extracted from the article]

Researchers from Kyushu University in Fukuoka, Japan have developed a gene delivery carrier that responds to the activated c-Src protein-tyrosine kinase. The carrier consists of a neutral main chain with a peptide substrate of c-Src, and when phosphorylated in the presence of c-Src, it releases DNA. In vitro and in vivo experiments showed that the carrier enabled specific gene expression in cells and tumors. This research provides promising insights into cancer gene therapy and the potential for targeted treatment. [Extracted from the article]

A new report from Kyushu University in Fukuoka, Japan discusses the prevalence and prognostic significance of high-risk human papillomavirus (HR-HPV) in squamous cell carcinoma of the hypopharynx, larynx, and oropharynx. The study found that HR-HPV infection was observed in 24% of tumors, with a higher prevalence in oropharyngeal squamous cell carcinoma (64.6%) compared to hypopharyngeal and laryngeal squamous cell carcinoma (0.4%). In cases of combined-type squamous cell carcinoma involving multiple sites, HR-HPV infection was observed in 25% of cases. The study suggests that HR-HPV infection may be rare in pure hypopharyngeal and laryngeal squamous cell carcinoma and that it may not improve prognosis in advanced disease stages. Further research with larger cohorts is needed to confirm these findings. [Extracted from the article]

Researchers at Kyushu University in Fukuoka, Japan have conducted a study on the effects of breast cancer cell-derived extracellular vesicles (EVs) on osteoblast differentiation and functions. The study found that these EVs inhibit the maturation of osteoblasts, which are responsible for bone formation. The researchers also discovered that the EVs regulate the activity of c-Jun N-terminal kinase (JNK), a protein involved in osteoblast differentiation. This research provides new insights into the impact of bone metastasis and the role of EVs in osteoblast differentiation. [Extracted from the article]

A study conducted at Kyushu University in Fukuoka, Japan, explored the use of a new MRI reconstruction technique called Multi-Resolution Convolutional Neural Network (MR CNN) for brain tumor classification. The researchers used the Figshare brain tumor dataset, consisting of 3064 T1-weighted contrast-enhanced MRI scans, to train the MR CNN model. They found that the proposed brain tumor classifier achieved a classification accuracy of 92.79% for a 10% sampling rate, outperforming other methods. The study concluded that MR CNN significantly improves the accuracy of brain tumor classification based on tumor location using under-sampled k-space signals. This research has been peer-reviewed. [Extracted from the article]

A recent study conducted at Fukuoka University Hospital in Japan explored the occurrence of chemotherapy-induced fatigue (CIF) in cancer patients undergoing chemotherapy. The study analyzed data from 415 patients and identified several risk factors for CIF, including nausea and vomiting, anorexia, hypoalbuminemia, and a high blood urea nitrogen/creatinine (BUN/Cr) ratio. The researchers concluded that early control of these risk factors could help healthcare providers avoid or reduce CIF and improve patients' quality of life. This study provides valuable insights for healthcare professionals in managing the side effects of chemotherapy. [Extracted from the article]

A recent study conducted by researchers at Kyushu University in Fukuoka, Japan, has explored the development of anti-cancer agents to target the tolerance of pancreatic cancer cells to nutritional starvation. The researchers used a chemical biology approach called the Ugi reaction to synthesize new anti-austerity agents and evaluate their effectiveness. One particular Ugi adduct, Ugi adduct 11, showed strong anti-austerity activity and preferential cytotoxicity against PANC-1 pancreatic cancer cells. The study also demonstrated the potential of the Ugi reaction-based chemical engineering of natural product extracts as a rapid method for discovering novel anti-austerity agents for combating pancreatic cancer. [Extracted from the article]

Researchers at Fukuoka University in Japan have reported new findings on adult T-cell leukemia-lymphoma (ATL), a hematopoietic malignancy with a poor prognosis that develops in approximately 5% of human T-cell leukemia virus type 1 (HTLV-1) carriers. The researchers investigated the effect of a novel CDK9 selective inhibitor, LY2857785, on ATL-related cell lines in vitro, freshly isolated cells from ATL patients ex vivo, and ATL tumor xenografts in mice. They found that LY2857785 significantly reduced cell viability, induced apoptosis, and suppressed the levels of anti-apoptotic protein MCL-1. The inhibitor also increased autophagy and decreased the growth of ATL tumor xenografts. These findings suggest that LY2857785 has potential as a treatment for ATL. [Extracted from the article]

A recent study conducted in Japan examined the survival outcomes of adult patients with head and neck para-meningeal rhabdomyosarcoma (PM-HNRMS), a rare form of soft tissue sarcoma. The study found that PM-HNRMS has a poor prognosis in adults, and there is limited data on salvage therapy. The research evaluated the overall survival and progression-free survival of patients who received first-line therapy, as well as the outcomes of patients who received salvage therapy after progressing against first-line treatment. The study concluded that salvage therapy, including local therapy for all detected lesions, may prolong survival in patients with PM-HNRMS. [Extracted from the article]

Keywords: Fukuoka; Japan; Asia; Cancer; Carcinomas; Health and Medicine; Hemic and Immune Systems; Immunology; Lymph Nodes; Lymphoid Tissue; Oncology; Risk and Prevention; Squamous Cell Carcinoma EN Fukuoka Japan Asia Cancer Carcinomas Health and Medicine Hemic and Immune Systems Immunology Lymph Nodes Lymphoid Tissue Oncology Risk and Prevention Squamous Cell Carcinoma 1327 1327 1 11/06/23 20231107 NES 231107 2023 NOV 6 (NewsRx) -- By a News Reporter-Staff News Editor at Clinical Oncology Week -- A new study on Oncology - Squamous Cell Carcinoma is now available. The news correspondents report that additional information may be obtained from Kaori Koga, Fukuoka University Hospital, Dept. of Pathology, 7-45-1 Nanakuma, Jonan Ku, Fukuoka 8140180, Japan. [Extracted from the article]

According to news reporting originating from Fukuoka, Japan, by NewsRx correspondents, research stated, "Pancreatic undifferentiated carcinoma (UDC) is a rare tumor with a worse prognosis than pancreatic ductal adenocarcinoma (PDAC). Fukuoka, Japan, Asia, Biomarkers, Cancer, Carcinomas, Diagnostics and Screening, Gastroenterology, Health and Medicine, Intermediate Filament Proteins, Oncology, Pancreas, Vimentin Keywords: Fukuoka; Japan; Asia; Biomarkers; Cancer; Carcinomas; Diagnostics and Screening; Gastroenterology; Health and Medicine; Intermediate Filament Proteins; Oncology; Pancreas; Vimentin EN Fukuoka Japan Asia Biomarkers Cancer Carcinomas Diagnostics and Screening Gastroenterology Health and Medicine Intermediate Filament Proteins Oncology Pancreas Vimentin 1487 1487 1 11/06/23 20231106 NES 231106 2023 NOV 6 (NewsRx) -- By a News Reporter-Staff News Editor at Gastroenterology Week -- Fresh data on Oncology - Carcinomas are presented in a new report. [Extracted from the article]

Fukuoka, Japan, Asia, Cancer, Follicular Lymphoma, Health and Medicine, Hematology, Immunoproliferative Disorders, Lymphatic Diseases and Conditions, Lymphoma, Lymphoproliferative Disorders, Oncology Keywords: Fukuoka; Japan; Asia; Cancer; Follicular Lymphoma; Health and Medicine; Hematology; Immunoproliferative Disorders; Lymphatic Diseases and Conditions; Lymphoma; Lymphoproliferative Disorders; Oncology EN Fukuoka Japan Asia Cancer Follicular Lymphoma Health and Medicine Hematology Immunoproliferative Disorders Lymphatic Diseases and Conditions Lymphoma Lymphoproliferative Disorders Oncology 2111 2111 1 10/30/23 20231031 NES 231031 2023 NOV 3 (NewsRx) -- By a News Reporter-Staff News Editor at Hematology Week -- Investigators publish new report on Oncology - Follicular Lymphoma. Our group previously reported that immune checkpoint (ICP) pathways, such as programmed cell death (PD-1) and programmed death ligand 1 (PD-L1), are poor prognostic factors for diffuse large B-cell lymphoma and adult T-cell leukemia/lymphoma.". [Extracted from the article]

Fukuoka, Japan, Asia, Cancer, Carcinomas, Health and Medicine, Liver Cancer, Oncology Keywords: Fukuoka; Japan; Asia; Cancer; Carcinomas; Health and Medicine; Liver Cancer; Oncology EN Fukuoka Japan Asia Cancer Carcinomas Health and Medicine Liver Cancer Oncology 570 570 1 10/24/23 20231024 NES 231024 2023 OCT 24 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- Fresh data on Oncology - Liver Cancer are presented in a new report. [Extracted from the article]

Keywords: Fukuoka; Japan; Asia; Alkylating Agents; Antineoplastics; Cancer; Chlorine Compounds; Cisplatin Therapy; Drugs and Therapies; Glottic Cancer; Glottic Carcinoma; Health and Medicine; Nitrogen Compounds; Oncology; Pharmaceuticals; Platinum Compounds; Radiation Therapy; Squamous Cell Carcinoma EN Fukuoka Japan Asia Alkylating Agents Antineoplastics Cancer Chlorine Compounds Cisplatin Therapy Drugs and Therapies Glottic Cancer Glottic Carcinoma Health and Medicine Nitrogen Compounds Oncology Pharmaceuticals Platinum Compounds Radiation Therapy Squamous Cell Carcinoma 602 602 1 10/24/23 20231024 NES 231024 2023 OCT 24 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- Investigators discuss new findings in Oncology - Squamous Cell Carcinoma. For more information on this research see: Comparative Treatment Outcome In T3n0 Glottic Cancer With and Without Vocal Fold Fixation Receiving Radiation Therapy and Concurrent Low-dose Intra-arterial Cisplatin Infusion. [Extracted from the article]

Keywords: Fukuoka; Japan; Asia; B-Cell Lymphoma; Blood Cells; Cancer; Epstein-Barr Virus; HHV-4; HHV4; Health and Medicine; Hematology; Hemic and Immune Systems; Human Herpesvirus 4; Human Herpesvirus Diseases and Conditions; Immunology; Immunoproliferative Disorders; Large B-Cell Lymphoma; Lymphatic Diseases and Conditions; Lymphocytes; Lymphoma; Lymphoproliferative Disorders; Mononuclear Leukocytes; Oncology; Tumor Virus Infections; Tumor Viruses; Viral; Virology EN Fukuoka Japan Asia B-Cell Lymphoma Blood Cells Cancer Epstein-Barr Virus HHV-4 HHV4 Health and Medicine Hematology Hemic and Immune Systems Human Herpesvirus 4 Human Herpesvirus Diseases and Conditions Immunology Immunoproliferative Disorders Large B-Cell Lymphoma Lymphatic Diseases and Conditions Lymphocytes Lymphoma Lymphoproliferative Disorders Mononuclear Leukocytes Oncology Tumor Virus Infections Tumor Viruses Viral Virology 740 740 1 10/24/23 20231026 NES 231026 2023 OCT 27 (NewsRx) -- By a News Reporter-Staff News Editor at Hematology Week -- Investigators publish new report on Human Herpesvirus Diseases and Conditions - Epstein-Barr Virus. Keywords for this news article include: Fukuoka, Japan, Asia, B-Cell Lymphoma, Blood Cells, Cancer, Epstein-Barr Virus, HHV-4, HHV4, Health and Medicine, Hematology, Hemic and Immune Systems, Human Herpesvirus 4, Human Herpesvirus Diseases and Conditions, Immunology, Immunoproliferative Disorders, Large B-Cell Lymphoma, Lymphatic Diseases and Conditions, Lymphocytes, Lymphoma, Lymphoproliferative Disorders, Mononuclear Leukocytes, Oncology, Tumor Virus Infections, Tumor Viruses, Viral, Virology, Fukuoka University. [Extracted from the article]

According to the news reporters, the research concluded: "A multicenter survey study in Japan showed FS treatment for young AEH and EC patients in compliance with the indications is feasible." In this survey, we confirmed that FS treatment in Japan is centered on MPA alone and in combination with metformin, and that the treatment efficacy is similar to that reported in previous reports." Keywords: Fukuoka; Japan; Asia; Cancer; Endometrial Cancer; Endometrial Hyperplasia; Health and Medicine; Obstetrics; Obstetrics and Gynecology; Oncology; Risk and Prevention; Uterine Diseases and Conditions; Women's Health EN Fukuoka Japan Asia Cancer Endometrial Cancer Endometrial Hyperplasia Health and Medicine Obstetrics Obstetrics and Gynecology Oncology Risk and Prevention Uterine Diseases and Conditions Women's Health 1012 1012 1 09/19/23 20230922 NES 230922 2023 SEP 19 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- New research on Uterine Diseases and Conditions - Endometrial HyperplAsia is the subject of a report. [Extracted from the article]

Fukuoka, Japan, Asia, Amino Acids, Basic Amino Acids, Cancer, Chemotherapy, Diamino Amino Acids, Drugs and Therapies, Glutamine, Health and Medicine, Lung Cancer, Lung Diseases and Conditions, Lung Neoplasms, Neutral Amino Acids, Oncology, Pharmaceuticals Keywords: Fukuoka; Japan; Asia; Amino Acids; Basic Amino Acids; Cancer; Chemotherapy; Diamino Amino Acids; Drugs and Therapies; Glutamine; Health and Medicine; Lung Cancer; Lung Diseases and Conditions; Lung Neoplasms; Neutral Amino Acids; Oncology; Pharmaceuticals EN Fukuoka Japan Asia Amino Acids Basic Amino Acids Cancer Chemotherapy Diamino Amino Acids Drugs and Therapies Glutamine Health and Medicine Lung Cancer Lung Diseases and Conditions Lung Neoplasms Neutral Amino Acids Oncology Pharmaceuticals 245 245 1 09/19/23 20230922 NES 230922 2023 SEP 19 (NewsRx) -- By a News Reporter-Staff News Editor at Drug Week -- Current study results on Oncology - Lung Cancer have been published. [Extracted from the article]

FIB-4 index at 6 months after NA treatment and serum AFP levels at 6 months after NA treatment were predictors for the development of HCC in patients with HBV during NA treatment." Keywords: Fukuoka; Japan; Asia; Biological Factors; Biological Tumor Markers; Cancer; Carcinomas; DNA Viruses; Digestive System Diseases and Conditions; Drugs and Therapies; Fetal Proteins; Gastroenterology; Health and Medicine; Hepadnaviridae; Hepadnaviridae Infections; Hepatitis; Hepatitis B Virus; Infectious Diseases and Conditions; Liver Cancer; Liver Diseases and Conditions; Oncology; Orthohepadnavirus; Risk and Prevention; Therapy; Viral; alpha-Fetoproteins EN Fukuoka Japan Asia Biological Factors Biological Tumor Markers Cancer Carcinomas DNA Viruses Digestive System Diseases and Conditions Drugs and Therapies Fetal Proteins Gastroenterology Health and Medicine Hepadnaviridae Hepadnaviridae Infections Hepatitis Hepatitis B Virus Infectious Diseases and Conditions Liver Cancer Liver Diseases and Conditions Oncology Orthohepadnavirus Risk and Prevention Therapy Viral alpha-Fetoproteins 728 728 1 09/19/23 20230919 NES 230919 2023 SEP 19 (NewsRx) -- By a News Reporter-Staff News Editor at Hepatitis Weekly -- Research findings on Liver Diseases and Conditions - Hepatitis B Virus are discussed in a new report. [Extracted from the article]

Keywords: Fukuoka; Japan; Asia; Cancer; Chemotherapy; Drugs and Therapies; Gastroenterology; Genetics; Health and Medicine; Oncology; Rectal Cancer; Surgery EN Fukuoka Japan Asia Cancer Chemotherapy Drugs and Therapies Gastroenterology Genetics Health and Medicine Oncology Rectal Cancer Surgery 1207 1207 1 09/19/23 20230919 NES 230919 2023 SEP 19 (NewsRx) -- By a News Reporter-Staff News Editor at Immunotherapy Weekly -- Investigators discuss new findings in Oncology - Rectal Cancer. Fukuoka, Japan, Asia, Cancer, Chemotherapy, Drugs and Therapies, Gastroenterology, Genetics, Health and Medicine, Oncology, Rectal Cancer, Surgery. [Extracted from the article]

Keywords: Fukuoka; Japan; Asia; Alkylating Agents; Antineoplastic Monoclonal Antibodies; Antineoplastics; Atezolizumab Therapy; Bevacizumab Therapy; Cancer; Carboplatin Therapy; Cycloparaffins; Diterpenes; Drugs and Therapies; Health and Medicine; Hydrocarbons; Immunologic Agents; Immunotherapy; Lung Cancer; Lung Diseases and Conditions; Lung Neoplasms; Mitotic Inhibitors; Monoclonal Antibodies; Non-Small Cell Lung Cancer; Oncology; Organic Chemicals; Organoplatinum Compounds; Paclitaxel Therapy; Pharmaceuticals; Taxoids; Terpenes; Tyrosine Kinase Inhibitors; VEGF - VEGFR Inhibitors; VEGFR Inhibitors EN Fukuoka Japan Asia Alkylating Agents Antineoplastic Monoclonal Antibodies Antineoplastics Atezolizumab Therapy Bevacizumab Therapy Cancer Carboplatin Therapy Cycloparaffins Diterpenes Drugs and Therapies Health and Medicine Hydrocarbons Immunologic Agents Immunotherapy Lung Cancer Lung Diseases and Conditions Lung Neoplasms Mitotic Inhibitors Monoclonal Antibodies Non-Small Cell Lung Cancer Oncology Organic Chemicals Organoplatinum Compounds Paclitaxel Therapy Pharmaceuticals Taxoids Terpenes Tyrosine Kinase Inhibitors VEGF - VEGFR Inhibitors VEGFR Inhibitors 511 511 1 09/11/23 20230914 NES 230914 2023 SEP 12 (NewsRx) -- By a News Reporter-Staff News Editor at Immunotherapy Weekly -- A new study on Oncology - Non-Small Cell Lung Cancer is now available. According to the news editors, the research concluded: "ABCP therapy for Japanese non-squamous NSCLC patients in a clinical setting achieved a high response rate with low incidence of ICI-induced pneumonitis equivalent to those observed in IMpower150 study.". [Extracted from the article]

Keywords: Fukuoka; Japan; Asia; Adenocarcinoma; Cancer; Gastroenterology; Health and Medicine; Oncology; Pancreas; Surgery EN Fukuoka Japan Asia Adenocarcinoma Cancer Gastroenterology Health and Medicine Oncology Pancreas Surgery 453 453 1 09/04/23 20230908 NES 230908 2023 SEP 4 (NewsRx) -- By a News Reporter-Staff News Editor at Medical Devices & Surgical Technology Week -- New research on Oncology - Adenocarcinoma is the subject of a report. The median overall survival (OS) and disease-free survival (DFS) of patients with osteosarcopenia were significantly shorter than those of patients without osteosarcopenia (OS: 23 and 48 months, respectively, P< 0.001; DFS: 13.4 and 21.2 months, respectively, P = 0.004). [Extracted from the article]

Keywords: Fukuoka; Japan; Asia; Cancer; Cytokines; Genetics; Health and Medicine; Immunology; Intercellular Signaling Peptides and Proteins; Interleukin-1; Interleukins; Lung Cancer; Lung Diseases and Conditions; Lung Neoplasms; Monokines; Non-Small Cell Lung Cancer; Oncology; Peptides; Proteins EN Fukuoka Japan Asia Cancer Cytokines Genetics Health and Medicine Immunology Intercellular Signaling Peptides and Proteins Interleukin-1 Interleukins Lung Cancer Lung Diseases and Conditions Lung Neoplasms Monokines Non-Small Cell Lung Cancer Oncology Peptides Proteins 1120 1120 1 09/04/23 20230905 NES 230905 2023 SEP 5 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- Investigators publish new report on Oncology - Non-Small Cell Lung Cancer. IL-1 beta and IFN-gamma also cooperatively activated mitogen- activated protein kinase (MAPK) signaling and promoted the binding of downstream transcription factors to the PD-L1 gene promoter. [Extracted from the article]

Keywords: Fukuoka; Japan; Asia; Anticancer Agents; Cancer; Cancer Therapy; Drugs and Therapies; Emerging Technologies; Health and Medicine; Nanoparticles; Nanotechnology; Oncology; Protective Agents EN Fukuoka Japan Asia Anticancer Agents Cancer Cancer Therapy Drugs and Therapies Emerging Technologies Health and Medicine Nanoparticles Nanotechnology Oncology Protective Agents 751 751 1 08/28/23 20230829 NES 230829 2023 AUG 29 (NewsRx) -- By a News Reporter-Staff News Editor at Clinical Oncology Week -- Investigators discuss new findings in Cancer. Fukuoka, Japan, Asia, Anticancer Agents, Cancer, Cancer Therapy, Drugs and Therapies, Emerging Technologies, Health and Medicine, Nanoparticles, Nanotechnology, Oncology, Protective Agents. [Extracted from the article]

According to news reporting originating from Fukuoka, Japan, by NewsRx correspondents, research stated, "Early detection of hypopharyngeal squamous cell carcinoma (SCC) is important for both an improved prognosis and less-invasive treatment. Keywords: Fukuoka; Japan; Asia; Cancer; Carcinomas; Endoscopy; Health and Medicine; Minimally Invasive Surgical Procedures; Oncology; Squamous Cell Carcinoma; Surgery EN Fukuoka Japan Asia Cancer Carcinomas Endoscopy Health and Medicine Minimally Invasive Surgical Procedures Oncology Squamous Cell Carcinoma Surgery 675 675 1 07/31/23 20230801 NES 230801 2023 AUG 1 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- Investigators publish new report on Oncology - Squamous Cell Carcinoma. [Extracted from the article]

For more information on this research see: Inhibition of Transcription and Antiproliferative Effects In a Cancer Cell Line Using Antigene Oligonucleotides Containing Artificial Nucleoside Analogues. Keywords: Fukuoka; Japan; Asia; Artificial Nucleic Acids; Bioengineering; Biomedical Engineering; Biomedicine; Biotechnology; Cancer; Cell Line; Drugs and Therapies; Genetics; Health and Medicine; Oncology; Pharmaceuticals EN Fukuoka Japan Asia Artificial Nucleic Acids Bioengineering Biomedical Engineering Biomedicine Biotechnology Cancer Cell Line Drugs and Therapies Genetics Health and Medicine Oncology Pharmaceuticals 120 120 1 07/17/23 20230721 NES 230721 2023 JUL 20 (NewsRx) -- By a News Reporter-Staff News Editor at Drug Week -- Investigators discuss new findings in Bioengineering - Artificial Nucleic Acids. [Extracted from the article]

Each parameter was compared between TERTw and TERTm using the Mann-Whitney U test. Correlations between parameters derived from MRS and DWI were also evaluated.ResultsNAA/Cr and Cho/Cr were both higher for TERTw than for TERTm. The aim of this study was to identify features from MR spectroscopy (MRS) and multi-exponential models of DWI distinguishing wild-type TERT (TERTw) from TERT promoter mutation (TERTm) in IDH-wildtype diffuse astrocytic glioma. [Extracted from the article]

Keywords: Fukuoka; Japan; Asia; Angiosarcomas; Cancer; Genetics; Health and Medicine; Oncology EN Fukuoka Japan Asia Angiosarcomas Cancer Genetics Health and Medicine Oncology 737 737 1 07/03/23 20230704 NES 230704 2023 JUL 4 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- Researchers detail new data in Oncology - Angiosarcomas. Fukuoka, Japan, Asia, Angiosarcomas, Cancer, Genetics, Health and Medicine, Oncology. [Extracted from the article]

Aberrant beta-catenin activation is also observed in acute myeloid leukemia (AML), and crucially contributes to self-renewal and propagation of leukemic stem cells (LSCs) regardless of mutations in contrast with such solid tumors." Keywords: Fukuoka; Japan; Asia; Acute Myeloid Leukemia; Armadillo Domain Proteins; Cancer; Catenins; Enzymes and Coenzymes; Health and Medicine; Hematology; Kinase; Leukemia; Myeloid Leukemia; Oncology; Proteins; Transcription Factors; beta Catenin EN Fukuoka Japan Asia Acute Myeloid Leukemia Armadillo Domain Proteins Cancer Catenins Enzymes and Coenzymes Health and Medicine Hematology Kinase Leukemia Myeloid Leukemia Oncology Proteins Transcription Factors beta Catenin 260 260 1 07/03/23 20230704 NES 230704 2023 JUL 4 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- Current study results on Oncology - Acute Myeloid Leukemia have been published. [Extracted from the article]

Keywords: Fukuoka; Japan; Asia; Cancer; Cancer Detection; Health and Medicine; Oncology; Prostate Cancer; Prostatic Neoplasms EN Fukuoka Japan Asia Cancer Cancer Detection Health and Medicine Oncology Prostate Cancer Prostatic Neoplasms 722 722 1 05/29/23 20230530 NES 230530 2023 MAY 30 (NewsRx) -- By a News Reporter-Staff News Editor at Clinical Oncology Week -- Fresh data on Oncology - Cancer Detection are presented in a new report. Fukuoka, Japan, Asia, Cancer, Cancer Detection, Health and Medicine, Oncology, Prostate Cancer, Prostatic Neoplasms. [Extracted from the article]